Inclusion of underrepresented groups in preclinical Alzheimer disease trials—opportunities abound

JJ Manly, A Gilmore-Bykovskyi, KD Deters - JAMA Network Open, 2021 - jamanetwork.com
In the search for treatments to delay or halt the progression of Alzheimer disease (AD),
researchers see promise in clinical trials that enroll people without cognitive decline who …
被引用次数：25 相关文章

[引用][C] Inclusion of Underrepresented Groups in Preclinical Alzheimer Disease Trials-Opportunities Abound.

JJ Manly, A Gilmore-Bykovskyi, KD Deters - JAMA Network Open, 2021 - europepmc.org
Inclusion of Underrepresented Groups in Preclinical Alzheimer Disease Trials-Opportunities
Abound. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu …
[PDF] archive.org

[PDF][PDF] Inclusion of Underrepresented Groups in Preclinical Alzheimer Disease Trials—Opportunities Abound

JJ Manly, A Gilmore-Bykovskyi, KD Deters - scholar.archive.org
In the search for treatments to delay or halt the progression of Alzheimer disease (AD),
researchers see promise in clinical trials that enroll people without cognitive decline who …

[引用][C] Inclusion of Underrepresented Groups in Preclinical Alzheimer Disease Trials-Opportunities Abound

JJ Manly, A Gilmore-Bykovskyi… - JAMA network …, 2021 - pubmed.ncbi.nlm.nih.gov
Inclusion of Underrepresented Groups in Preclinical Alzheimer Disease Trials-Opportunities
Abound Inclusion of Underrepresented Groups in Preclinical Alzheimer Disease Trials-Opportunities …